Centre de Médecine Héraclès: what changed
Centre de Médecine Héraclès
Largest movements
- Cash -€302,785
down €302,785 (-84.8%), from €357,152 to €54,367
mainly Receivables within one year (-€231,220) and Other debts (-€209,783)
- Receivables within one year +€231,220
up €231,220 (+195%), from €118,598 to €349,818
of which Other amounts receivable: +€230,553
- Tangible fixed assets -€53,823
down €53,823 (-14.0%), from €383,849 to €330,026
of which Plant, machinery and equipment: -€39,203
- Deferred charges and accrued income +€9,288
up €9,288 (+404%), from €2,298 to €11,586
- Other debts -€209,783
no longer reported in 2025 (was €209,783)
- Reserves +€130,198
up €130,198 (+38.5%), from €337,974 to €468,172
- Debts after one year -€31,484
down €31,484 (-13.4%), from €235,137 to €203,653
- Gross operating margin -€10,701
down €10,701 (-4.1%), from €263,279 to €252,578
- Financial income +€5,991
up €5,991 (+87.5%), from €6,846 to €12,837
- Staff costs +€5,107
up €5,107 (+48.0%), from €10,636 to €15,743
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €862,746 | €746,647 | -€116,099 | -13.5% |
| Fixed assets | 21/28 | €384,699 | €330,876 | -€53,823 | -14.0% |
| Tangible fixed assets | 22/27 | €383,849 | €330,026 | -€53,823 | -14.0% |
| Land and buildings | 22 | €124,616 | €119,538 | -€5,079 | -4.1% |
| Plant, machinery and equipment | 23 | €240,991 | €201,789 | -€39,203 | -16.3% |
| Furniture and vehicles | 24 | €18,241 | €8,700 | -€9,541 | -52.3% |
| Financial fixed assets | 28 | €850 | €850 | = | 0.0% |
| Current assets | 29/58 | €478,047 | €415,771 | -€62,276 | -13.0% |
| Amounts receivable within one year | 40/41 | €118,598 | €349,818 | +€231,220 | +195% |
| Trade receivables | 40 | €5,206 | €5,873 | +€667 | +12.8% |
| Other amounts receivable | 41 | €113,392 | €343,945 | +€230,553 | +203% |
| Cash at bank and in hand | 54/58 | €357,152 | €54,367 | -€302,785 | -84.8% |
| Deferred charges and accrued income | 490/1 | €2,298 | €11,586 | +€9,288 | +404% |
| Total equity and liabilities | 10/49 | €862,746 | €746,647 | -€116,099 | -13.5% |
| Equity | 10/15 | €337,974 | €468,172 | +€130,198 | +38.5% |
| Reserves | 13 | €337,974 | €468,172 | +€130,198 | +38.5% |
| Distributable reserves | 133 | €337,974 | €468,172 | +€130,198 | +38.5% |
| Amounts payable | 17/49 | €524,772 | €278,475 | -€246,297 | -46.9% |
| Amounts payable after more than one year | 17 | €235,137 | €203,653 | -€31,484 | -13.4% |
| Financial debts | 170/4 | €235,137 | €203,653 | -€31,484 | -13.4% |
| Amounts payable within one year | 42/48 | €282,118 | €74,771 | -€207,347 | -73.5% |
| Current portion of amounts payable after more than one year | 42 | €30,676 | €31,484 | +€808 | +2.6% |
| Trade debts | 44 | €3,252 | €1,759 | -€1,493 | -45.9% |
| Suppliers | 440/4 | €3,252 | €1,759 | -€1,493 | -45.9% |
| Taxes, remuneration and social security | 45 | €38,406 | €41,528 | +€3,121 | +8.1% |
| Taxes | 450/3 | €37,233 | €40,500 | +€3,267 | +8.8% |
| Remuneration and social security | 454/9 | €1,174 | €1,028 | -€146 | -12.4% |
| Other amounts payable | 47/48 | €209,783 | - | -€209,783 | |
| Accrued charges and deferred income | 492/3 | €7,517 | €51 | -€7,466 | -99.3% |
| Remuneration, social security and pensions | 62 | €10,636 | €15,743 | +€5,107 | +48.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €54,757 | €53,823 | -€934 | -1.7% |
| Other operating charges | 640/8 | €1,123 | €1,245 | +€122 | +10.9% |
| Gross operating margin | 9900 | €263,279 | €252,578 | -€10,701 | -4.1% |
| Operating profit (loss) | 9901 | €196,763 | €181,767 | -€14,996 | -7.6% |
| Financial income | 75/76B | €6,846 | €12,837 | +€5,991 | +87.5% |
| Recurring financial income | 75 | €6,846 | €12,837 | +€5,991 | +87.5% |
| Financial charges | 65/66B | €6,643 | €5,884 | -€759 | -11.4% |
| Recurring financial charges | 65 | €6,643 | €5,846 | -€796 | -12.0% |
| Non-recurring financial charges | 66B | - | €37 | +€37 | |
| Profit (loss) for the period before taxes | 9903 | €196,967 | €188,721 | -€8,246 | -4.2% |
| Income taxes | 67/77 | €61,124 | €58,523 | -€2,601 | -4.3% |
| Profit (loss) for the period | 9904 | €135,843 | €130,198 | -€5,645 | -4.2% |
| Profit (loss) for the period to be appropriated | 9905 | €135,843 | €130,198 | -€5,645 | -4.2% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 6 November 2026 via checked.be.